Prelude Capital Management’s RxSight RXST Stock Holding History

Prelude Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.6K	Buy	+10,000	New	+$83K	﹤0.01%	1108

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Prelude Capital Management's RXST Position: Q1 2026 in Review

Prelude Capital Management opened a new position in RxSight (RXST) in Q1 2026: 10,000 shares worth $61.6K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings.

164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Prelude Capital Management held 10,000 shares of RxSight worth $61.6K as of Q1 2026.
RxSight was a new Prelude Capital Management position in Q1 2026.
RxSight made up ﹤0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1108 holding.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.